First Outcomes of Anti-IL5 Biological Therapy in Patients with Severe Asthma in Croatia
D. Rnjak (Zagreb, Croatia), A. Štajduhar (Zagreb, Croatia), S. Popovic-Grle (Zagreb, Croatia), N. Ferara (Šibenik, Croatia), I. Jelavic (Zagreb, Croatia), M. Lampalo (Zagreb, Croatia)
Source: International Congress 2022 – Studies targeting IL-5 pathways in asthma
Session: Studies targeting IL-5 pathways in asthma
Session type: Thematic Poster
Number: 2130
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Rnjak (Zagreb, Croatia), A. Štajduhar (Zagreb, Croatia), S. Popovic-Grle (Zagreb, Croatia), N. Ferara (Šibenik, Croatia), I. Jelavic (Zagreb, Croatia), M. Lampalo (Zagreb, Croatia). First Outcomes of Anti-IL5 Biological Therapy in Patients with Severe Asthma in Croatia. 2130
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|